Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,026,717
+$357,654 QoQ
Shares Held
37,249
-4.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#265
of 751 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL PLC holds $29,580,493 across 10 Biotechnology names. EXEL ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,710 | $9,790,548 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
24,557 | $4,599,034 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,829 | $3,634,614 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
35,365 | $2,768,018 | |
| 5 | INSM |
INSMED Inc
|
24,458 | $2,607,711 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,696 | $2,316,726 | |
| 7 | EXEL |
Exelixis, Inc.
This page
|
37,249 | $2,026,717 | |
| 8 | INCY |
Incyte Corp
|
7,710 | $874,005 |
All Filings in EXEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,026,717 | 37,249 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,669,063 | 38,915 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,719,763 | 84,868 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,066,108 | 98,453 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,455,826 | 101,085 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,289,085 | 143,258 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,118,014 | 33,574 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||